Table 1.
Baseline characteristics of the study participants.
| n = 117 | |
|---|---|
| Age in years | 63.5 ± 9.9 |
| Female | 40 (34) |
| BMI in kg/m2 | 27.8 ± 4.4 |
| Obesity (BMI ≥ 30 kg/m2) | 30 (26) |
| Creatinine at admission in mg/dL | 0.87 ± 0.19 |
| GFR at admission in mL/minute | 83.3 ± 16.0 |
| STEMI | 46 (39) |
| NSTE-ACS | 71 (61) |
| NSTEMI | 24 (21) |
| UA | 47 (40) |
| Integral ticagrelor tablets | 86 (74) |
| Morphine administration | 33 (28) |
| History of CAD | 35 (30) |
| Nonhemorrhagic stroke | 9 (8) |
| LVEF at discharge <50% | 59 (50) |
| Hypertension | 75 (64) |
| Diabetes mellitus | 25 (21) |
| Dyslipidemia | 104 (89) |
| Current smoker | 43 (37) |
Data are shown as mean ± standard deviation or number (%). BMI: body mass index, CAD: coronary artery disease, GFR: glomerular filtration rate, LVEF: left ventricle ejection fraction, NSTE-ACS: non-ST-elevation acute coronary syndrome, NSTEMI: non-ST-elevation myocardial infarction, STEMI: ST-elevation myocardial infarction, UA: unstable angina.